| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0034 | 0.9 |